Corey Williams
Corey Williams's Latest Posts
eot-position-update-November-5-2014
November 5, 2014 Market Snapshot The midterm elections are over. And it looks like Wall Street is happy with the outcome. More importantly, there’s strong seasonality for stocks during the 4th quarter of a midterm election year and the 1st quarter of the following year. According to the Stock Trader’s Almanac, the S&P 500 has […]
SET Portfolio Update November 2014
November 4, 2014 The stock market rebound that began in mid-October continued to pick up steam right through the end of the month. Amazingly, the S&P 500 has already recovered the 10% pullback. And it’s even made a new 52-week high this week. The way I see it, 3rd quarter earnings are the main reason […]
eot-position-update-October-29-2014
October 29, 2014 Market Snapshot Well, that’s the end of QE. The Fed’s bond buying program that has helped support the economy over the last six years came to an end this week. The Fed now has a mindboggling $4 trillion worth of assets on its balance sheet. One thing’s for sure, QE has been […]
BST Position Update: October 23, 2014
October 23, 2014 . . . . Merrimack Pharmaceuticals (NASDAQ: MACK) – Hold MACK has bucked the trend of most biotech stocks this year. It has been in a strong uptrend despite the overall weakness in small-cap biotech stocks. The stock is now at a 52-week high of $9.17. That represents a jaw dropping 347% […]
eot-position-update-October-22-2014
October 22, 2014 Market Snapshot For one reason or another, we almost always see a market correction this time of year. And this year’s September/October pullback was no exception. After reaching a high of 2,019 on September 19th, the S&P 500 plummeted nearly 200 points by October 15th. The 9.8% drop ended one of the […]
SET Monthly Issue October 2014
October 2014 TIS THE SEASON TO OPEN YOUR WALLET October is living up to its billing as one of the most volatile months for stocks. After reaching a new all-time high of 2,019 in September, the S&P 500 tumbled 10% lower over the next four weeks. As it so often does, the pullback triggered fears […]
BST Trade Alert: October 17, 2014
October 17, 2014 Recommendation: Buy Arena Pharmaceuticals (NASDAQ: ARNA) up to $5.00 About the Company: Arena Pharmaceuticals brings innovative medicines targeting G protein-coupled receptors to patients. They launched their first approved drug, BELVIQ ® (lorcaserin HCl), in 2013. Arena is focused on discovering, developing, and commercializing additional drugs to address unmet medical needs. The company has an […]
eot-trade-alert-October-15-2014
October 15, 2014 Trade Alert: Buy GLOG February 20th 2015 $20.00 Calls at $1.95 or better Company Background: GasLog (GLOG) owns and operates a fleet of liquefied natural gas (LNG) carriers. Short-Term Catalyst: GasLog is one of my favorite companies. We’ve used call options to profit from a previous upswing earlier this year. The marketwide […]
eot-position-update-October-15-2014
October 15, 2014 Market Snapshot And that’s how it ends… The S&P 500 had been above the 200-day moving average since November 19, 2012. On Monday, the S&P fell below this key technical support level. Who knew that Ebola can infect a stock market? All kidding aside, we just witnessed the end of one of […]
BST Market Update: October 10, 2014
October 10, 2014 Investing in developmental stage biotech stocks often feels like we’re mining for diamonds. We have to dig through tons of worthless dirt to find the few jewels that make it worth the effort. There’s no denying the rewards of biotech investing are unlike anything else when we find one of these diamonds. […]
